Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leigh Ellis

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer SubgroupDavid P Labbé, Christopher J Sweeney, Myles Brown, et al.
The Journal of Clinical Investigation|March 28, 2024
Mediator kinase inhibition reverses castration resistance of advanced prostate cancerJing Li, Thomas A Hilimire, Yueying Liu, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate CancerChen Qian, Qian Yang, Mirja Rotinen, et al.
The Journal of Clinical Investigation|November 19, 2024
Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in miceKatherine L Morel, Beatriz Germán, Anis A Hamid, et al.
Nature Cell Biology|December 4, 2023
Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatmentJenna M Giafaglione, Preston D Crowell, Amelie M L Delcourt, et al.
Nucleic Acids Research|June 27, 2024
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancerChen Qian, Qian Yang, Mirja Rotinen, et al.
Cancer Cell|April 18, 2025
Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiationMona Teng, Jiacheng Guo, Xin Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 2018
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancerGiorgia Zadra, Caroline F Ribeiro, Paolo Chetta, et al.
Blood Cancer Discovery|December 13, 2022
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough InfectionsMaryam I Azeem, Ajay K Nooka, Uma Shanmugasundaram, et al.
Cancer Research|June 4, 2024
Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate CancerNadia Boufaied, Paolo Chetta, Tarek Hallal, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer SubgroupDavid P Labbé, Christopher J Sweeney, Myles Brown, et al.
The Journal of Clinical Investigation|March 28, 2024
Mediator kinase inhibition reverses castration resistance of advanced prostate cancerJing Li, Thomas A Hilimire, Yueying Liu, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate CancerChen Qian, Qian Yang, Mirja Rotinen, et al.
The Journal of Clinical Investigation|November 19, 2024
Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in miceKatherine L Morel, Beatriz Germán, Anis A Hamid, et al.
Nature Cell Biology|December 4, 2023
Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatmentJenna M Giafaglione, Preston D Crowell, Amelie M L Delcourt, et al.
Nucleic Acids Research|June 27, 2024
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancerChen Qian, Qian Yang, Mirja Rotinen, et al.
Cancer Cell|April 18, 2025
Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiationMona Teng, Jiacheng Guo, Xin Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 2018
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancerGiorgia Zadra, Caroline F Ribeiro, Paolo Chetta, et al.
Blood Cancer Discovery|December 13, 2022
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough InfectionsMaryam I Azeem, Ajay K Nooka, Uma Shanmugasundaram, et al.
Cancer Research|June 4, 2024
Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate CancerNadia Boufaied, Paolo Chetta, Tarek Hallal, et al.
Pageof 7